Companies Related to "The Efficacy of Deferring BCG Vaccination to 14 Weeks of Age in HIV-1 Exposed Infants in Uganda" [Most Relevant Company Matches] RSS

20:21 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "The Efficacy of Deferring BCG Vaccination to 14 Weeks of Age in HIV-1 Exposed Infants in Uganda" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Deferring Vaccination Weeks Exposed Infants Uganda" Companies 1–25 of 546



UviCube (Kokirri, LLC) was created in 2012. UviCube eliminates 99.9% of harmful bacteria when exposed to ultraviolet (UV) light. Dry and store baby bottles, pacifiers and cups until you need them. Because UviCube uses UV light, mobile phones, electronics, toys and other items that cannot be exposed to moisture or heat can be conveniently sanitized. UviCube...

IPTi Consortium

IPTi is the administration of an anti-malarial tablet to infants, two or three times in the first year of life, deliverable alongside established vaccination programmes such as WHO's Expanded Programme for Immunisation. It is inexpensive (each dose costs between USD $0.13 - $0.23)(v,vi) and cost effective. IPTi with SP has been reviewed by a committee of the US National Academy of Sciences' In...

Styrene Information and Research Center (SIRC)

1 Collins, JJ, Bodner, KM, Bus, JS. Cancer Mortality of Workers Exposed to Styrene in the US Reinforced Plastics and Composite Industry. Epidemiology, March 2013, 24(2), 195-203.


ALK-Abelló is the world-leading producer of pharmaceuticals for specific allergy vaccination. Not only do our allergy vaccines treat the allergic symptoms, but also the underlying causes of allergy – and at the same time they prevent asthma.ALK-Abelló has been active in allergy vaccination since 1923. In recent years, we have pursued a product development strategy of extending the current mar...

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...

Racing Ahead

Racing Ahead is a leading provider of assessment and early intervention services for infants and toddlers at risk for developmental delays. Racing Ahead's staff serves as a knowledgeable resource for expert advice, information, intervention, and support for both parents and physicians. Racing Ahead also provides parent workshops and individualized instruction for infants and toddlers to accelera...

10 Weeks BodyChange

FIT Biotech

FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies

Women and Infants Hospital of Rhode Island

Mead Johnson & Company

Mead Johnson Nutritionals is a world leader in nutrition, dedicated to providing infants and children with the best start in life. With more than 70 products in over 60 countries, its products are trusted by parents and health care professionals around the world. In 2005, Mead Johnson celebrated a historic event - its centennial anniversary. Mead Johnson was founded in 1905 by Edward Mead Johnson ...

Wherever the Need

Founded in 1997, Wherever the Need seeks to alleviate poverty and ill health through the implementation of sanitation, water and livelihoods, and in a manner that empowers individuals and communities without undermining their traditions and cultures. WTN collaborates with developing countries, such as India, Kenya, Uganda and Sierra Leone, to provide sanit...


First3Years educates, advocates, and collaborates to advance the healthy development of infants and toddlers. We have trained and mentored thousands of professionals across the state on brain development, attachment, separation, trauma, self-regulation, cross-cultural awareness, and other infant mental health related issues. We know that supporting the soc...

Prolacta Bioscience, Inc.

Prolacta Bioscience, Inc. ( is a life science company dedicated to improving quality of life by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill premature infants in Neonatal Intensive Care Units. It is the first and only company to p...

Probably Relevant

ALK Abello A/S

ALK Abello develops, produces and distributes effective, innovative products for the diagnosis, prevention, relief of allergic symptoms and cure of allergies.ALK Abello's R&D activities focus on specific allergy diagnosis and vaccination.

Nuevolution A/S

Nuevolution is a leading small molecule lead discovery company founded in 2001 and based in Copenhagen, Denmark. The company has developed Chemetics®, a unique, patent protected hybrid of proven wet chemistry and molecular biology which represents the ultimate fragment based drug discovery technology. Chemetics® enables rapid oligonucleotide e.g. DNA encoded synthesis of up to billions o...

Thrust Health, LLC

In a society fully exposed to the benefits of high-powered pharmaceutical solutions to sexual dysfunction, Thrust Health has developed the first-ever preventative care program and comprehensive wellness package designed to enhance sexual performance for both men and women – for use in the privacy of their home.

Rasna Therapeutics , Inc.

Rasna Therapeutics, Inc. is a biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. The company has a balanced...

Rasna Therapeutics, Inc.

Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. The comp...

sanofi pasteur S.A.

It is rare for a company's history to be so tightly interwoven with the history of a major health care discovery. Sanofi pasteur is the result of the meeting of three exceptional destinies, those of men who left their mark on the history of vaccination: Louis Pasteur, the Mérieux family and John FitzGerald. These three destinies very likely converged because they were all moving in the same direc...

Sympore GmbH

Sympore is a pharmaceutical discovery enterprise focusing on the mechanisms by which drugs enter and move through the body. Sympore uses its insights to modify compounds for improved uptake and distribution thus increasing efficacy and reducing side effects. To achieve significant improvements in bioavailability, Sympore employs pro-drug strategies and has identified a series of promising carriers...

Seva Foundation

Seva Foundation is a California-based charitable organization whose mission is to restore sight and prevent blindness in the developing world. They believe that giving sight to a blind person is a particularly effective way to relieve suffering, reduce poverty and transform lives. Seva works in more than 20 countries in need of sustainable services includi...

Augmenix, Inc.

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or efficacy. Augmenix's first product, SpaceOAR system is an injectable tissue spacer that will decrease rectal morbidity or enable improved efficacy in prostate radiotherapy. The company was founded in ...

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human efficacy related to muscle cramping in healthy volunteers. The Company plans to initiate efficacy studies in patients with neuromuscular disorders in the first half of 2015. Additiona...

Clinical Innovations

Clinical Innovations develops, manufactures and markets state-of-the-art medical devices with particular emphasis on improving outcomes for women and their infants (

PURE Bioscience, Inc.

PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and le...

More From BioPortfolio on "The Efficacy of Deferring BCG Vaccination to 14 Weeks of Age in HIV-1 Exposed Infants in Uganda"

Quick Search


Corporate Database Quicklinks